|
LSM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.691800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.072000E-01 |
| Normal-vs-Stage2 |
4.030400E-01 |
| Normal-vs-Stage3 |
2.215600E-01 |
| Normal-vs-Stage4 |
6.170200E-01 |
| Stage1-vs-Stage2 |
8.844200E-01 |
| Stage1-vs-Stage3 |
7.734200E-01 |
| Stage1-vs-Stage4 |
7.899800E-01 |
| Stage2-vs-Stage3 |
7.302000E-01 |
| Stage2-vs-Stage4 |
8.786400E-01 |
| Stage3-vs-Stage4 |
6.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.889360E-01 |
| Normal-vs-AfricanAmerican |
1.170850E-01 |
| Normal-vs-Asian |
9.866600E-01 |
| Caucasian-vs-AfricanAmerican |
8.532400E-01 |
| Caucasian-vs-Asian |
6.249800E-01 |
| AfricanAmerican-vs-Asian |
5.991400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.769000E-01 |
| Normal-vs-Female |
3.054400E-01 |
| Male-vs-Female |
6.252000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.097800E-01 |
| Normal-vs-Extreme_Weight |
9.916300E-02 |
| Normal-vs-Obese |
5.732000E-01 |
| Normal-vs-Extreme_Obese |
8.051000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.205000E-01 |
| Normal_Weight-vs-Obese |
2.988600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.301600E-01 |
| Extreme_Weight-vs-Obese |
1.044380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.062000E-01 |
| Obese-vs-Extreme_Obese |
9.242000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.870030E-01 |
| Normal-vs-Age(41-60Yrs) |
9.239600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.081600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.952600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.442800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.722600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.196800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.823600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.799800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.131000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.595900E-02 |
| Normal-VS-Type2 PRCC |
9.257400E-01 |
| Normal-VS-KIRP CIMP |
9.655800E-01 |
| Normal-VS-Unclassified PRCC |
6.869800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.514470E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.793400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.328200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.886000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.841400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.087400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.021200E-01 |
| Normal-vs-N1 |
3.264200E-01 |
| Normal-vs-N2 |
5.429400E-01 |
| N0-vs-N1 |
3.955200E-01 |
| N0-vs-N2 |
6.563600E-01 |
| N1-vs-N2 |
8.519200E-01 |
|
|
